These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33213461)

  • 1. Emerging insights into the relationship between hyperlipidemia and the risk of diabetic retinopathy.
    Chou Y; Ma J; Su X; Zhong Y
    Lipids Health Dis; 2020 Nov; 19(1):241. PubMed ID: 33213461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipids and other risk factors for diabetic retinopathy in Chinese type 2 diabetic patients.
    Zhang HY; Wang JY; Ying GS; Shen LP; Zhang Z
    J Zhejiang Univ Sci B; 2013 May; 14(5):392-9. PubMed ID: 23645176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids and Diabetic Retinopathy.
    Modjtahedi BS; Bose N; Papakostas TD; Morse L; Vavvas DG; Kishan AU
    Semin Ophthalmol; 2016; 31(1-2):10-8. PubMed ID: 26959124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic retinopathy and serum lipids.
    Su DH; Yeo KT
    Singapore Med J; 2000 Jun; 41(6):295-7. PubMed ID: 11109348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlipidemia-Mediated Increased Advanced Lipoxidation End Products Formation, an Important Factor Associated with Decreased Erythrocyte Glucose-6-Phosphate Dehydrogenase Activity in Mild Nonproliferative Diabetic Retinopathy.
    Choudhuri S; Roy PK; Mitra B; Sen S; Sarkar R; Das M; Biswas D; Ghosh P; Biswas A; Chakraborty S; Mondal LK
    Can J Diabetes; 2017 Feb; 41(1):82-89. PubMed ID: 27916496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Statin Therapy With Prevention of Vision-Threatening Diabetic Retinopathy.
    Kang EY; Chen TH; Garg SJ; Sun CC; Kang JH; Wu WC; Hung MJ; Lai CC; Cherng WJ; Hwang YS
    JAMA Ophthalmol; 2019 Apr; 137(4):363-371. PubMed ID: 30629109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies.
    Jenkins AJ; Grant MB; Busik JV
    Diabetologia; 2022 Apr; 65(4):587-603. PubMed ID: 35149880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk.
    Duntas L; Kolovou G
    Future Cardiol; 2011 Mar; 7(2):137-44. PubMed ID: 21453018
    [No Abstract]   [Full Text] [Related]  

  • 9. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema.
    Gupta A; Gupta V; Thapar S; Bhansali A
    Am J Ophthalmol; 2004 Apr; 137(4):675-82. PubMed ID: 15059707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy.
    Chung YR; Park SW; Choi SY; Kim SW; Moon KY; Kim JH; Lee K
    Cardiovasc Diabetol; 2017 Jan; 16(1):4. PubMed ID: 28061854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents.
    Dupuy AM; Carrière I; Scali J; Cristol JP; Ritchie K; Dartigues JF; Gambert P; Ancelin ML
    Climacteric; 2008 Feb; 11(1):74-83. PubMed ID: 18202967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperlipidemia and the development of diabetic retinopathy: Comparison between type 1 and type 2 animal models.
    Kowluru RA; Mishra M; Kowluru A; Kumar B
    Metabolism; 2016 Oct; 65(10):1570-81. PubMed ID: 27621192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with Diabetes.
    Vail D; Callaway NF; Ludwig CA; Saroj N; Moshfeghi DM
    Am J Ophthalmol; 2019 Nov; 207():378-384. PubMed ID: 31194953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of CYP3A4 2 and eNOS genes in the diabetic patients with hyperlipidemia undergoing statin treatment.
    Jamil K; Kandula V; Kandula R; Asimuddin M; Joshi S; Yerra SK
    Mol Biol Rep; 2014 Oct; 41(10):6719-27. PubMed ID: 24996290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
    Gouni-Berthold I; Krone W
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence and persistence to hyperlipidemia medications in patients with atherosclerotic cardiovascular disease and those with diabetes mellitus based on administrative claims data in Japan.
    Wake M; Oh A; Onishi Y; Guelfucci F; Shimasaki Y; Teramoto T
    Atherosclerosis; 2019 Mar; 282():19-28. PubMed ID: 30669019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatment options for lipid-lowering therapy in subjects with type 2 diabetes.
    Scicali R; Di Pino A; Ferrara V; Urbano F; Piro S; Rabuazzo AM; Purrello F
    Acta Diabetol; 2018 Mar; 55(3):209-218. PubMed ID: 29260404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipids: diagnosis and therapy in type 2 diabetes].
    Wascher TC; Paulweber B; Toplak H; Saely C; Drexel H
    Wien Klin Wochenschr; 2012 Dec; 124 Suppl 2():28-30. PubMed ID: 23250461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.